# Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

> **NCT05643690** · — · SUSPENDED · sponsor: **AnchorDx Medical Co. Ltd. US** · enrollment: 77 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** UriFind Bladder Cancer Assay

## Key facts

- **NCT ID:** NCT05643690
- **Lead sponsor:** AnchorDx Medical Co. Ltd. US
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-11-18
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** Protocol amendment.
- **Last updated:** 2024-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05643690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05643690, "Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05643690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*